Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-09-05 5:03 pm Purchase | 13G | Paratek Pharmaceuticals Inc. PRTK | CONTINENTAL GENERAL INSURANCE CO | 3,693,981 6.400% | 3,693,981 (New Position) | View |
| 2023-06-27 08:20 am Unchanged | 13D | Paratek Pharmaceuticals Inc. PRTK | NexPoint Real Estate Opportunities LLC | 6,692,447 11.690% | 0 (Unchanged) | View |
| 2023-03-30 4:30 pm Unchanged | 13D | Paratek Pharmaceuticals Inc. PRTK | NexPoint Real Estate Opportunities LLC | 6,692,447 11.690% | 0 (Unchanged) | View |
| 2023-03-20 08:08 am Sale | 13G | Paratek Pharmaceuticals Inc. PRTK | HIRSCHMAN ORIN | 2,802,115 4.900% | -1,354,776 (-32.59%) | View |
| 2023-02-15 07:18 am Purchase | 13G | Paratek Pharmaceuticals Inc. PRTK | HIRSCHMAN ORIN | 4,156,891 7.500% | 269,719 (+6.94%) | View |
| 2023-02-13 3:40 pm Sale | 13G | Paratek Pharmaceuticals Inc. PRTK | LYTTON LAURENCE W | 459,961 0.800% | -2,750,591 (-85.67%) | View |
| 2023-01-20 4:15 pm Purchase | 13G | Paratek Pharmaceuticals Inc. PRTK | NexPoint Real Estate Opportunities LLC | 3,870,197 6.970% | 3,870,197 (New Position) | View |
| 2022-07-08 4:57 pm Sale | 13G | Paratek Pharmaceuticals Inc. PRTK | BlackRock Inc. BLK | 869,224 1.600% | -2,108,456 (-70.81%) | View |
| 2022-07-07 2:58 pm Purchase | 13G | Paratek Pharmaceuticals Inc. PRTK | HIRSCHMAN ORIN | 3,887,172 7.700% | 1,067,105 (+37.84%) | View |
| 2022-05-18 4:47 pm Purchase | 13G | Paratek Pharmaceuticals Inc. PRTK | LYTTON LAURENCE W | 3,210,552 5.900% | 3,210,552 (New Position) | View |
| 2022-03-11 4:15 pm Purchase | 13G | Paratek Pharmaceuticals Inc. PRTK | DONDERO JAMES D | 2,892,197 5.700% | 2,892,197 (New Position) | View |
| 2022-03-09 08:10 am Purchase | 13G | Paratek Pharmaceuticals Inc. PRTK | HIRSCHMAN ORIN | 2,820,067 5.600% | 2,820,067 (New Position) | View |
| 2022-02-11 08:19 am Sale | 13G | Paratek Pharmaceuticals Inc. PRTK | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,239,937 4.270% | -237,547 (-9.59%) | View |
| 2022-02-02 7:11 pm Sale | 13G | Paratek Pharmaceuticals Inc. PRTK | BlackRock Inc. BLK | 2,977,680 5.900% | -469,649 (-13.62%) | View |
| 2021-02-12 4:47 pm Purchase | 13G | Paratek Pharmaceuticals Inc. PRTK | NEXPOINT ASSET MANAGEMENT L.P. | 2,301,555 5.000% | 2,301,555 (New Position) | View |
| 2021-02-09 08:20 am Purchase | 13G | Paratek Pharmaceuticals Inc. PRTK | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,477,484 5.150% | 98,553 (+4.14%) | View |
| 2021-01-29 5:22 pm Purchase | 13G | Paratek Pharmaceuticals Inc. PRTK | BlackRock Inc. BLK | 3,447,329 7.600% | 1,123,417 (+48.34%) | View |
| 2020-02-14 4:58 pm Purchase | 13G | Paratek Pharmaceuticals Inc. PRTK | Highland Capital Management LP | 3,178,028 9.600% | 25,000 (+0.79%) | View |
| 2020-02-14 3:28 pm Sale | 13G | Paratek Pharmaceuticals Inc. PRTK | ARMISTICE CAPITAL LLC | 1,258,000 3.800% | -710,000 (-36.08%) | View |
| 2020-02-13 4:18 pm Sale | 13G | Paratek Pharmaceuticals Inc. PRTK | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,378,931 6.670% | -420,548 (-15.02%) | View |